Skip to main content

Table 1 Clinical characteristics of the patients with rheumatoid arthritis

From: Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis

Patient Disease duration
(months)
Site of surgery Gender Medication
1 180 Knee Female Prednisolone, 5 mg/d; celecoxib, 200 mg/d; gasmotine, 2.5 mg/d
2 36 Knee Female Cyclosporin A, 100 mg/d; triamcinolone, 2 mg/d
3 240 Knee Male Prednisolone, 5 mg/d; hydroxychloroquine, 200 mg/d; sulfasalazine, 500 mg/d
4 180 Hip Female Hydroxychloroquine, 200 mg/d
5 187 Knee Female Deflazacort, 5 mg/d; methotrexate, 12.5 mg/wk; leflunomide, 10 mg/d; hydroxychloroquine, 200 mg/d